Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  NASDAQ OMX HELSINKI LTD.  >  Revenio Group Oyj    REG1V   FI0009010912

REVENIO GROUP OYJ

(REG1V)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq Omx Helsinki Ltd.
07/08/2020 07/09/2020 07/10/2020 07/13/2020 07/14/2020 Date
28.1(c) 28.35(c) 28(c) 28.1(c) 27.95 Last
13 521 14 590 14 100 12 499 10 534 Volume
-1.06% +0.89% -1.23% +0.36% -0.53% Change
More quotes
Financials
Sales 2020 54,3 M 61,6 M 61,6 M
Net income 2020 10,7 M 12,1 M 12,1 M
Net Debt 2020 3,77 M 4,28 M 4,28 M
P/E ratio 2020 70,3x
Yield 2020 1,17%
Sales 2021 70,5 M 80,1 M 80,1 M
Net income 2021 17,4 M 19,7 M 19,7 M
Net cash position 2021 5,13 M 5,82 M 5,82 M
P/E ratio 2021 42,9x
Yield 2021 1,71%
Capitalization 744 M 846 M 845 M
EV / Sales 2020 13,8x
EV / Sales 2021 10,5x
Nbr of Employees 126
Free-Float 80,0%
More Financials
Company
Revenio Group Oyj, formerly Done Solutions Oyj, is a Finland-based company primarily engaged in the health technology segment. The Company’s activities are divided into two business areas: Revenio Health Tech, which is responsible for the design, manufacture and sale of tonometers and bone density measurement devices; as well as Revenio Technology and Services, which provides contact center services for material... 
More about the company
Surperformance© ratings of Revenio Group Oyj
Trading Rating : Investor Rating :
More Ratings
Latest news on REVENIO GROUP OYJ
06/26REVENIO GROUP CORPORATION : Managers' Transactions
AQ
06/11REVENIO GROUP CORPORATION : Revenio's CEO has taken out a loan granted by the co..
AQ
06/09REVENIO GROUP OYJ : Ex-dividend day for final dividend
FA
06/08REVENIO GROUP CORPORATION : Decisions by the Annual General Meeting
AQ
06/05CORRECTION TO REVENIO GROUP CORPORAT : Notice pursuant to chapter 9, section 5 o..
AQ
06/05REVENIO GROUP CORPORATION : Managers' Transactions
AQ
06/05REVENIO GROUP CORPORATION :  Notice pursuant to chapter 9, section 5 of the secu..
AQ
06/05REVENIO GROUP CORPORATION : Increased number of shares entered into trade regist..
AQ
05/13REVENIO GROUP CORPORATION : Notice of the Annual General Meeting
AQ
05/04REVENIO GROUP CORPORATION : Jouni Toijala, Revenio's new CEO, will take duty on ..
AQ
04/22REVENIO GROUP CORPORATION : Interim Report, January 1 - March 31, 2020
PU
04/20REVENIO GROUP CORPORATION : Increased number of shares entered into trade regist..
AQ
04/02REVENIO GROUP CORPORATION :  Revenio Group Corporation will withdraw its earning..
AQ
03/31REVENIO GROUP CORPORATION :  Jouni Toijala appointed as the CEO of Revenio Group..
AQ
03/20REVENIO GROUP PLC : Share repurchase 20.03.2020
AQ
More news
News in other languages on REVENIO GROUP OYJ
06/26REVENIO GROUP CORPORATION : Managers' Transactions
06/11REVENIO GROUP CORPORATION : Revenio's CEO has taken out a loan granted by the co..
06/09REVENIO GROUP OYJ : Ex-dividend day for final dividend
06/08REVENIO GROUP CORPORATION : Decisions by the Annual General Meeting
06/05CORRECTION TO REVENIO GROUP CORPORAT : Notice pursuant to chapter 9, section 5 o..
More news
Chart REVENIO GROUP OYJ
Duration : Period :
Revenio Group Oyj Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends REVENIO GROUP OYJ
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 2
Average target price 24,20 €
Last Close Price 28,10 €
Spread / Highest target -11,0%
Spread / Average Target -13,9%
Spread / Lowest Target -16,7%
EPS Revisions
Managers
NameTitle
Jouni Erik Toijala President & Chief Executive Officer
Pekka Veikko Juhani Rönkä Chairman
Ari Isomäki Operations Director
Robin Allan Pulkkinen Chief Financial Officer
Mika Salkola Director-Research & Development
Sector and Competitors
1st jan.Capitalization (M$)
REVENIO GROUP OYJ114.10%846
SARTORIUS AG47.43%22 336
CELLAVISION AB (PUBL)-13.05%725
VAREX IMAGING CORPORATION-49.38%588
CO-DIAGNOSTICS, INC.1,851.52%480
OXFORD IMMUNOTEC GLOBAL PLC-23.19%331